Dantrium Intravenous (dantrolene Sodium For Injection): Presence Of Particulate Matter

Dantrium Intravenous Recall Summary Dantrium Intravenous (Dantrolene sodium for injection) is being recalled across Canada because some vials contain particulate matter (small particles in the solution). This is a Class I recall, meaning the product could cause serious harm. The recall affects all Dantrium Intravenous products distributed by Knight Therapeutics Inc. in Canada.

Recalling firm

Knight Therapeutics Inc.100 boul. Alexis-Nihon

Product

Dantrium Intravenous (Dantrolene sodium for injection)

Reason

Contamination

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2026-10-19

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/aaec0254-4f56-45c4-af23-623263837748